RedHill Biopharma Investor Relations Material
Latest events
H1 2025
5 Sep, 2025
Corporate Presentation
8 Jun, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from RedHill Biopharma Ltd
Access all reports
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company focused on the development and commercialization of treatments for gastrointestinal and infectious diseases. The company markets a portfolio of approved products in the United States and is also engaged in clinical development programs targeting conditions such as Crohn’s disease, Helicobacter pylori infection, and COVID-19. RedHill conducts research and commercial activities both independently and through strategic partnerships. The company is headquartered in Tel Aviv, Israel, and its shares are listed on the NASDAQ.
Key slides for RedHill Biopharma Ltd
Corporate Presentation
RedHill Biopharma Ltd
Corporate Presentation
RedHill Biopharma Ltd
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
RDHL
Country
🇺🇸 United States